Hillsborough-based InnerOptic (www.inneroptic.com), a medical visualization and technology company, has announced it will close on $370,000 in venture capital funding in the coming days. The company is developing 3D surgical-visualization technology, called InVision, designed to help doctors “see� better in performing minimally invasive surgery. InnerOptic hopes to win final Food and Drug Administration approval for InVision next year. The firm, launched in 2003 with technology licensed from UNC-Chapel Hill, has received a variety of federal grants and some angel funding. InnerOptic is expecting to raise $4.3 million by March 2008 to further refine its products and to add staff.
InnerOptic is a CED member.